feed,title,long_url,short_url
SeekingAlpha,ChemoCentryx solid tumors candidate shows immune stimulation properties in phase 1 trial,https://seekingalpha.com/news/3823063,
SeekingAlpha,"Oncternal deprioritizes development of ONCT-216, to focus on zilovertamab phase 3 trial",https://seekingalpha.com/news/3823064,
SeekingAlpha,Teresa Burchfield joins Sidus Space as CFO,https://seekingalpha.com/news/3823062,
